Compounds comprising self-immolative group
Provided are compounds comprising a self-immolative group, and the compounds comprising a self-immolative group according to the present invention may include a protein (for example, an oligopeptide, a polypeptide, an antibody, or the like) having substrate-specificity for a target and an active agent (for example, a drug, a toxin, a ligand, a detection probe, or the like) having a specific function or activity.
1. A compound represented by Formula I:
wherein:
Ar is nitrophenyl;
G is a glucuronic acid moiety or
wherein R 3 is hydrogen or a carboxyl protecting group, and each R 4 is independently hydrogen or a hydroxyl protecting group;
Q is an, azide, aldehyde, ketone, trialkylsilyl, or alkyne;
L is linker connecting Q and W;
W is —C(O)—, —C(O)NR′—, —C(O)O—, —SO 2 NR′—, —P(O)R″NR′—, —SONR′—, or —PO 2 NR′—, in each case where the C(O), S, or P is directly bound to the phenyl ring, and R′ and R″ are each independently hydrogen, (C 1 -C 8 )alkyl, (C 3 -C 8 )cycloalkyl, (C 1 -C 8 )alkoxy, (C 1 -C 8 )alkylthio, mono- or di-(C 1 -C 8 )alkylamino, (C 3 -C 20 )heteroaryl or (C 6 -C 20 )aryl;
Z is hydrogen, (C 1 -C 8 )alkyl, halogen, cyano or nitro;
n is an integer of 1 to 3, and when n is an integer of 2 or more, each of the Z(s) are the same as or different from each other; and
R 1 and R 2 are each independently hydrogen, (C 1 -C 8 )alkyl, or (C 3 -C 8 )cycloalkyl;
wherein either:
A) L is an alkylene chain having 1 to 50 carbon atoms and satisfies at least one of the following (i) to (iv):
(i) the alkylene includes at least one unsaturated bond,
(ii) the alkylene includes at least one heteroarylene,
(iii) at least one carbon atom of the alkylene is replaced with one or more heteroatoms selected from nitrogen (N), oxygen (O), and sulfur (S), and phosphorus (P), or
(iv) the alkylene is substituted with one or more alkyls having 1 to 20 carbon atoms; or
B) L includes at least one isoprenyl derivative unit represented by Formula A:
2. The compound of claim 1 , wherein G is
R 3 is hydrogen or a carboxyl protecting group, and R 4 (s) are each independently hydrogen or a hydroxyl-protecting group.
3. The compound of claim 1 , wherein W is —C(O)—, —C(O)NR′—, or —C(O)O—.
4. The compound of claim 1 , wherein L is an alkylene having 1 to 50 carbon atoms and satisfies at least one of the following (i) to (iv):
(i) the alkylene includes at least one unsaturated bond,
(ii) the alkylene includes at least one heteroarylene,
(iii) at least one carbon atom of the alkylene is replaced with one or more heteroatoms selected from nitrogen (N), oxygen (O), and sulfur (S), and
(iv) the alkylene is substituted with one or more alkyls having 1 to 20 carbon atoms.
5. The compound of claim 4 , wherein L is an alkylene having 1 to 50 carbon atoms and satisfies at least one of (i) or (ii):
(i) the alkylene includes at least one unsaturated bond, and
(ii) at least one carbon atom of the alkylene is replaced with one or more heteroatoms selected from nitrogen (N), oxygen (O), and sulfur (S).
6. The compound of claim 1 , wherein L includes at least one isoprenyl derivative unit represented by the following Chemical Formula A, which is recognized by an isoprenoid transferase:
7. The compound of claim 4 , wherein L further includes a connection unit represented by the following Chemical Formula F or G:
—(CH 2 ) r (V(CH 2 ) p ) q — [Chemical Formula F]
—(CH 2 CH 2 X) w — [Chemical Formula G]
V is a single bond, —O—, —S—, —NR 21 —, —C(O)NR 22 —, —NR 23 C(O)—, —NR 24 SO 2 —, or —SO 2 NR 25 —;
X is —O—, (C 1 -C 8 )alkylene, or —NR 21 —;
R 21 to R 25 are each independently hydrogen, (C 1 -C 6 )alkyl, (C 1 -C 6 )alkyl(C 6 -C 20 )aryl, or (C 1 -C 6 )alkyl(C 3 -C 20 )heteroaryl;
r is an integer of 1 to 10;
p is an integer of 0 to 10;
q is an integer of 1 to 10; and
w is an integer of 1 to 10.
8. The compound of claim 1 , wherein Q is a trimethylsilyl, azide, or alkyne.
9. The compound of claim 1 , wherein the compound is selected from compounds having one of the following structures:
wherein:
Ar is nitrophenyl;
Z is hydrogen, (C 1 -C 8 )alkyl, halogen, cyano, or nitro;
X is —O—, (C 1 -C 8 )alkylene, or —NR 21 —;
R 21 is hydrogen, (C 1 -C 6 )alkyl, (C 1 -C 6 )alkyl(C 6 -C 20 )aryl, or (C 1 -C 6 )alkyl(C 3 -C 20 )heteroaryl;
n is an integer of 1 to 3, and when n is an integer of 2 or more, each of the Z(s) are the same as or different from each other;
r is an integer of 1 to 10;
q is an integer of 1 to 10;
w is an integer of 1 to 10; and
x is an integer of 0 to 10.
10. The compound of claim 1 , wherein Ar is 3-nitrophenyl.
11. A compound represented by formula II:
wherein:
G is a glucuronic acid moiety or
wherein R 3 is hydrogen or a carboxyl protecting group, and each R 4 is independently hydrogen or a hydroxyl protecting group;
Q is an amine, azide, trialkylsilyl, aldehyde, ketone, hydroxylamine, or alkyne;
L is linker connecting Q and W,
B is an active agent;
W is —C(O)—, —C(O)NR′—, —C(O)O—, —SO 2 NR′—, —P(O)R″NR′—, —SONR′—, or —PO 2 NR′—, in each case where the C(O), S, or P is directly bound to the phenyl ring, and R′ and R″ are each independently hydrogen, (C 1 -C 8 )alkyl, (C 3 -C 8 )cycloalkyl, (C 1 -C 8 )alkoxy, (C 1 -C 8 )alkylthio, mono- or di-(C 1 -C 8 )alkylamino, (C 3 -C 20 )heteroaryl or (C 6 -C 20 )aryl;
Z is hydrogen, (C 1 -C 8 )alkyl, halogen, cyano, or nitro;
n is an integer of 1 to 3, and when n is an integer of 2 or more, each of the Z(s) are the same as or different from each other; and
R 1 and R 2 are each independently hydrogen, (C 1 -C 8 )alkyl or (C 3 -C 8 )cycloalkyl;
wherein either:
A) L is an alkylene chain having 1 to 50 carbon atoms and satisfies at least one of the following (i) to (iv):
(i) the alkylene includes at least one unsaturated bond,
(ii) the alkylene includes at least one heteroarylene,
(iii) at least one carbon atom of the alkylene is replaced with one or more heteroatoms selected from nitrogen (N), oxygen (O), and sulfur (S), and phosphorus (P), or
(iv) the alkylene is substituted with one or more alkyls having 1 to 20 carbon atoms; or
B) L includes at least one isoprenyl derivative unit represented by Formula A:
12. The compound of claim 11 , wherein G is
R 3 is hydrogen or a carboxyl protecting group, and R 4 (s) are each independently hydrogen or a hydroxyl-protecting group.
13. The compound of claim 11 , wherein W is —C(O)—, —C(O)NR′—, or —C(O)O—.
14. The compound of claim 11 , wherein L is an alkylene having 1 to 50 carbon atoms and satisfies at least one of the following (i) to (iv):
(i) the alkylene includes at least one unsaturated bond,
(ii) the alkylene includes at least one heteroarylene,
(iii) at least one carbon atom of the alkylene is replaced with one or more heteroatoms selected from nitrogen (N), oxygen (O), and sulfur (S), and
(iv) the alkylene is substituted with one or more alkyls having 1 to 20 carbon atoms.
15. The compound of claim 14 , wherein L is an alkylene having 1 to 50 carbon atoms and satisfies at least one of (i) or (ii):
(i) the alkylene includes at least one unsaturated bond, and
(ii) at least one carbon atom of the alkylene is replaced with one or more heteroatoms selected from nitrogen (N), oxygen (O), and sulfur (S).
16. The compound of claim 11 , wherein L includes at least one isoprenyl derivative unit represented by the following Chemical Formula A, which is recognized by an isoprenoid transferase:
17. The compound of claim 11 , wherein L further includes a connection unit represented by the following Chemical Formula F or G:
—(CH 2 ) r (V(CH 2 ) p ) q — [Chemical Formula F]
—(CH 2 CH 2 X) w — [Chemical Formula G]
V is a single bond, —O—, —S—, —NR 21 —, —C(O)NR 22 —, —NR 23 C(O)—, —NR 24 SO 2 —, or —SO 2 NR 25 —;
X is —O—, (C 1 -C 8 )alkylene, or —NR 21 —;
R 21 to R 25 are each independently hydrogen, (C 1 -C 6 )alkyl, (C 1 -C 6 )alkyl(C 6 -C 20 )aryl, or (C 1 -C 6 )alkyl(C 3 -C 20 )heteroaryl;
r is an integer of 1 to 10;
p is an integer of 0 to 10;
q is an integer of 1 to 10; and
w is an integer of 1 to 10.
18. The compound of claim 11 , wherein Q is an amine, trimethylsilyl, azide, or alkyne.
19. The compound of claim 11 , wherein the active agent is a drug, a toxin, an affinity ligand, a detection probe, or a combination thereof.
20. The compound of claim 11 , wherein the active agent is an immunomodulatory compound, an anticancer agent, an antiviral agent, an antibacterial agent, an antifungal agent, an antiparasitic agent, or a combination thereof.
21. The compound of claim 11 , wherein the compound is selected from compounds having one of the following structures:
wherein:
Z is hydrogen, (C 1 -C 8 )alkyl, halogen, cyano, or nitro;
X is —O—, (C 1 -C 8 )alkylene, or —NR 21 —;
R 21 is hydrogen, (C 1 -C 6 )alkyl, (C 1 -C 6 )alkyl(C 6 -C 20 )aryl, or (C 1 -C 6 )alkyl(C 3 -C 20 )heteroaryl;
n is an integer of 1 to 3, and when n is an integer of 2 or more, each of the Z(s) are the same as or different from each other;
r is an integer of 1 to 10;
q is an integer of 1 to 10;
w is an integer of 1 to 10;
x is an integer of 0 to 10; and
B is a drug having a structure selected from the following structures
and
y is an integer of 1 to 10.